| Holder | Position | Change | Date | |
|---|---|---|---|---|
| Marshall Wace LLP | 0.51% | 0 | 03-Dec-2025 | View History |
| AQR Capital Management, LLC | 0.5% | 0 | 12-May-2025 | View History |
| Holder | Position | Change (%) | Date | |
|---|---|---|---|---|
| BlackRock Investment Management (UK) Limited | 0.59% | 21-May-2013 | View History | |
| BlackRock Investment Management (UK) Limited | 0.69% | 09-Apr-2013 | View History | |
| BlackRock Investment Management (UK) Limited | 0.73% | 15-Mar-2013 | View History | |
| BlackRock Investment Management (UK) Limited | 0.88% | 05-Mar-2013 | View History | |
| BlackRock Investment Management (UK) Limited | 1.04% | 01-Mar-2013 | View History | |
| BlackRock Investment Management (UK) Limited | 1.19% | 25-Feb-2013 | View History | |
| BlackRock Investment Management (UK) Limited | 1.25% | 07-Feb-2013 | View History | |
| BlackRock Investment Management (UK) Limited | 1.3% | 05-Feb-2013 | View History | |
| BlackRock Investment Management (UK) Limited | 1.21% | 01-Nov-2012 | View History |
Hikma Pharmaceuticals is a British multinational pharmaceutical company, founded in 1978, that develops, manufactures, and markets a wide range of generic, branded, and in-licensed pharmaceutical products, with a focus on making high-quality medicines accessible.
Hikma share price launched at 281p in 2005.